Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) - MyClad - EMD Serono Research & Development Institute, Inc.See more
Stroke
A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE - LIBREXIASTROKE - Bristol Myers Squibb Company (BMS)See more
